Mutations in the riboflavin biosynthesis pathway confer resistance to furazolidone and abolish the synergistic interaction between furazolidone and vancomycin in Escherichia coli

Wykes HLe VVHRakonjac J2024-11-192024-11-192024-07-17https://mro.massey.ac.nz/handle/10179/72030(c) 2024 The Author/sCC BY 4.0https://creativecommons.org/licenses/by/4.0/Mutations in the riboflavin biosynthesis pathway confer resistance to furazolidone and abolish the synergistic interaction between furazolidone and vancomycin in Escherichia coliother10.1101/2024.07.17.603971preprint